Diagnostic Value of Serum CYFRA 21-1 in Lung Cancer.
10.4046/trd.1995.42.2.149
- Author:
Hyun Dae YOON
1
;
Ki Deok KIM
;
Jin Hong CHUNG
;
Hyung Woo LEE
;
Kwan Ho LEE
;
Hyun Woo LEE
;
Ihn Ho CHO
Author Information
1. Department of Internal Medicine, College of Medicine, Yeungnam University, Taegu, Korea.
- Publication Type:Original Article
- Keywords:
CYFRA 21-1;
Lung cancer
- MeSH:
Adenocarcinoma;
Carcinoma, Non-Small-Cell Lung;
Carcinoma, Squamous Cell;
Diagnosis;
Epitopes;
Humans;
Keratin-19;
Lung Neoplasms*;
Lung*;
Pneumonia;
Pulmonary Disease, Chronic Obstructive;
Sensitivity and Specificity;
Small Cell Lung Carcinoma;
Trees;
Tuberculosis, Pulmonary
- From:Tuberculosis and Respiratory Diseases
1995;42(2):149-155
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Cytokeratin 19 is 40KD acidic molecule whose distribution is restricted to simple or pseudo-stratified epithelia, such as the epithelial layer of the bronchial tree. Immunohistochemical study have shown that cytokeratin 19 is overexpressed in lung carcinoma tissue. An immunora- diometric assay, CYFRA 21-1 has been developed using two monoclonal antibody, BM 19-21 and KS 19-1, reactive to different epitopes on cytokeratin 19. We studied the diagnostic value of CYFRA 21-1 in lung cancer. METHOD: The serum CYFRA 21-1 level using immunoradiometric kit(ELSA-CYFRA 21-1) was measured in 54 patients who admit to Yeungnam University Hospital from April, 1993 to August, 1994. Lung cancer group was 39 primary lung cancer patients(19 patients with squamous cell carcinoma, 11 patients with adenocarcinoma and 9 patients with small cell carcinoma). Control group was 15 patients with non malignant lung diseases(8 patients with pulmonary tuberculosis, 3 patients with chronic obstructive pulmonary disease, 2 patients with pneumonia and 2 patients with chronic obstructive pulmonary disease combined with pulmonary tuberculosis). RESULTS: The mean serum value of CYFRA 21-1 was 20.2 +/- 4.7ng/ml in squamous cell carcinoma, 7.2 +/- 1.6ng/ml in adenocarcinoma and 15.5 +/- 4.7ng/ml in non-small cell lung cancer. The serum value of CYFRA 21-1 in control group was 1.7 +/- 0.5ng/ml. All of the serum values of 3 histologic types were significantly higher than that of control group(p<0.01). The serum value of CYFRA 21-1 of squamous cell carcinoma was significantly higher than that of adenocarcinoma(p <0.05). Serum value of CYFRA 21-1 in small cell lung cancer was 2.9 +/- 0.9ng/ml and not significantly different compared with control group. Using cut off value of 3.3ng/ml, sensitivity and specificity was 11.1%, 65.2% in small cell lung cancer, 70.0%, 62.5% in non-small cell lung cancer, 73.7%, 75% in squamous cell carcinoma and 63.6%, 78.9% in adenocarcinoma, respectively. CONCLUSION: The serum levels of CYFRA 21-1 may be useful in diagnosis of non-small cell lung carcinoma, especially in squamous cell carcinoma with its high specificity.
